Analysis of Seized Drug Samples by RADIAN™ ASAP Mass Detector

Analysis of Seized Drug Samples by RADIAN ASAP Mass Detector — Application Note (concise expert summary)

Significance of the topic:

The rapid and reliable identification of seized illicit drugs is a cornerstone of forensic chemistry, public safety and criminal justice. Rising seizure volumes and the continuous emergence of structurally novel psychoactive substances place heavy demands on laboratory throughput and forensic decision-making. Fast, robust presumptive screening methods that reduce burdens on confirmatory platforms (GC‑MS, LC‑HRMS) are therefore crucial to decrease backlogs, prioritize evidence for in-depth testing, and support timely operational responses.

Objectives and study overview:

This application note evaluates the RADIAN ASAP Mass Detector as a frontline, chromatography‑free screening tool for seized drug samples. The study tested 229 unknown case samples (tablets, powders, capsules) confiscated at entertainment venues. Results from RADIAN ASAP screening, employing a dip‑and‑detect workflow with multi‑voltage in‑source fragmentation and automated spectral library matching (AnalyzerPro XD), were compared with an established confirmatory HRMS screening workflow (15‑min LC separation on Xevo G3 QTof, MSE data acquisition). The principal aims were to assess identification concordance, reproducibility, operational speed, and practical suitability for routine forensic triage.

Methodology and analytical workflow:

- Sample extraction: Each specimen was sonicated in 5 mL methanol for 10 minutes; extracts were diluted 1:20 in methanol (additional dilutions as required). Capsule contents and powders were processed analogously.

- RADIAN ASAP sampling: A cleaned glass capillary was dipped ~1 cm into diluted extract for 5 seconds (dipping method), then introduced into the RADIAN ASAP ion source. Each sample underwent three consecutive dip‑and‑detect replicates using the same capillary.

- Data acquisition: Full‑scan MS over m/z 50–600 with four cone voltages (15, 25, 35, 50 V) to produce combined precursor and in‑source CID fragment spectra, yielding characteristic spectral fingerprints.

- Data processing: AnalyzerPro XD performed real‑time library matching against a curated seized‑drug reference spectral library. Identification scoring integrated forward/reverse fit, intensity thresholds, mass confirmation and ion‑ratio checks; spectra from all cone voltages contributed to a weighted final confidence percentage.

- Confirmatory HRMS: Selected samples were analyzed using a Forensic Toxicology HRMS Screening Solution (15‑min LC, Xevo G3 QTof, data‑independent acquisition MSE), with identifications based on retention time, accurate mass and fragment ions.

Used instrumentation:

• RADIAN ASAP Mass Detector (direct ionization, corona discharge + heated N2 vaporization).
• Glass capillaries for ASAP sample introduction (automated bakeout between uses).
• SpectralWorks AnalyzerPro XD software for spectral library matching and confidence scoring.
• Xevo G3 QTof Mass Spectrometer for confirmatory LC‑HRMS (15‑min chromatographic method, MSE/DIA).
• Routine laboratory consumables: methanol, glass vials, sonicator.

Main results and discussion:

- Identification performance: All 229 samples produced at least one positive library match at ≥85% confidence, yielding an apparent 100% true‑positive detection rate for this dataset relative to the study’s determinations. In total, 252 compound identifications were reported across the set, representing seven unique substances: MDMA (73.9% of IDs), amphetamine (4.3%), caffeine (4.3%), cocaine (4.3%), etizolam (4.3%), flualprazolam (4.3%), and paracetamol (4.3%). MDMA predominated and was often the sole detected component.

- Concordance with HRMS confirmatory testing: Strong qualitative agreement was observed between RADIAN ASAP and LC‑HRMS results. Discrepancies were mainly due to differences in analytical sensitivity and library coverage. In some groups HRMS detected additional cathinones and other novel compounds that were not present in the RADIAN reference library; conversely, RADIAN identified some compounds not initially reported by HRMS but still recovered the principal component in each case. Reproducibility of RADIAN match confidence across replicates and across groups containing the same compound was high, indicating analytical robustness.

- Limitations highlighted: The lack of chromatographic separation impedes the resolution of isomeric substances and complex mixtures; library incompleteness can limit detection of novel psychoactive substances; and differences in sensitivity may lead to non‑detection of low‑level components that LC‑HRMS detects.

Benefits and practical applications of the method:

• Speed and throughput: Direct analysis without chromatography significantly reduces per‑sample time and enables rapid triage.
• Minimal sample preparation: Simple sonication in methanol and dilution (1:20) streamline workflows and reduce consumable usage.
• Enhanced specificity for a direct method: Multi‑voltage in‑source fragmentation provides fragment‑ion information that improves spectral discrimination versus single‑ion mass matches.
• Ease of use and compact footprint: User‑friendly software (AnalyzerPro XD) with automated library matching supports non‑specialist operation and potential on‑site deployment.
• Operational impact: Practical for presumptive screening to prioritize samples for full confirmatory testing, reducing GC/LC‑MS backlog and enabling faster laboratory turnaround.

Future trends and potential applications:

• Reference library expansion and rapid updating are essential to maintain detection coverage for newly emerging psychoactive substances; RADIAN’s library can be updated quickly to address this need.
• Hybrid workflows pairing rapid RADIAN screening with targeted LC‑HRMS confirmation are likely to become standard practice for efficient case triage and defensible reporting consistent with SWGDRUG guidelines (Category A confirmation still required for definitive identification in many jurisdictions).
• Advances in spectral‑matching algorithms, machine learning models for deconvolution of mixed spectra, and enhanced in‑source fragmentation strategies could further improve specificity for complex samples.
• Potential development of quantitative or semi‑quantitative protocols, validation for casework admissibility, and integration into laboratory information management systems will increase routine utility.
• Field/portable adaptations and combined ambient ionization platforms may enable on‑site presumptive screening at seizure locations or at points of entry.

Conclusion:

The RADIAN ASAP Mass Detector provides a rapid, reproducible and user‑friendly direct‑ionization screening approach for seized drug materials. When combined with automated spectral library matching, it delivers high‑confidence presumptive identifications with minimal sample preparation and no chromatographic step. While not a substitute for category‑A confirmatory techniques (LC‑HRMS/GC‑MS) — particularly for isomer differentiation and trace‑level components — RADIAN ASAP is well suited as a frontline triage tool to improve laboratory throughput, reduce analytical bottlenecks, and accelerate case prioritization. Continuous updating of spectral libraries and complementary confirmatory testing remain critical for comprehensive forensic coverage.

References:

1. United Nations Office on Drugs and Crime. World Drug Report 2023. United Nations publication, 2023.
2. Wood M. RADIAN ASAP with LiveID—Fast, Specific, and Easy Drug Screening. Waters Application Note 720007125, 2021.
3. Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG). Recommendations, Edition 8.1, 19 August 2022.
4. Mistry N.; Calton L.J.; Cooper J. The Ultimate Forensic Toxicology Screening Companion—Xevo G3 QTof: The Utility of MSE for Toxicological Screening. Waters Application Brief 720008033, 2023.